S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Great Crypto Bull (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The "Smart Money" Is Ready for May 1st Are You? (Ad)
MarketBeat Week in Review – 4/15 - 4/19
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Great Crypto Bull (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The "Smart Money" Is Ready for May 1st Are You? (Ad)
MarketBeat Week in Review – 4/15 - 4/19
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Great Crypto Bull (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The "Smart Money" Is Ready for May 1st Are You? (Ad)
MarketBeat Week in Review – 4/15 - 4/19
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Great Crypto Bull (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The "Smart Money" Is Ready for May 1st Are You? (Ad)
MarketBeat Week in Review – 4/15 - 4/19
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Free Trial
OTCMKTS:BCTXF

BriaCell Therapeutics (BCTXF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free BCTXF Stock Alerts
$2.02
-0.13 (-6.05%)
(As of 04/19/2024 ET)
Compare
Today's Range
$2.01
▼
$2.29
50-Day Range
$2.15
▼
$3.75
52-Week Range
$3.25
▼
$17.50
Volume
41,777 shs
Average Volume
1,859 shs
Market Capitalization
$1.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines
BCTXF stock logo

About BriaCell Therapeutics Stock (OTCMKTS:BCTXF)

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

BCTXF Stock Price History

BCTXF Stock News Headlines

February 2, 2024 | msn.com
BriaCell’s Shareholders Approve Directors and Auditors
January 4, 2024 | finanznachrichten.de
BriaCell Therapeutics Corp.: BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast Cancer
April 20, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
November 15, 2023 | businesswire.com
MiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
October 25, 2023 | finance.yahoo.com
BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate
October 20, 2023 | finance.yahoo.com
October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative Technology
September 26, 2023 | theglobeandmail.com
Closing Bell: Briacell Therapeutics Corp flat on Monday (BCT)
September 10, 2023 | msn.com
BriaCell Therapeutics: Poised To Move To Advanced Trials, But An Unconvincing Thesis
April 20, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
September 8, 2023 | finance.yahoo.com
BriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer
August 18, 2023 | finance.yahoo.com
BriaCell Therapeutics Corp. Announces Voting Results From Special Meeting
August 17, 2023 | msn.com
BriaCell receives NCI grant for cancer platform development
July 22, 2023 | theglobeandmail.com
BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)
June 28, 2023 | markets.businessinsider.com
BriaCell Therapeutics (BCT) Gets a Buy Rating from H.C. Wainwright
May 25, 2023 | marketwatch.com
BriaCell Therapeutics in Definitive Agreement to Spin Off Certain Assets
May 25, 2023 | msn.com
BriaCell to spin out BriaPro Therapeutics
April 27, 2023 | theglobeandmail.com
BriaCell Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BCT)
April 7, 2023 | theglobeandmail.com
Closing Bell: Briacell Therapeutics Corp down on Thursday (BCT)
April 1, 2023 | morningstar.com
Toronto Stocks Advance as Banking Sector Sentiment Improves; BriaCell Slides on Spinoff Plans
March 30, 2023 | marketwatch.com
BriaCell Therapeutics to Spin Off Certain Assets
February 23, 2023 | marketwatch.com
BriaCell Sees Positive Survival Data in Ongoing Trial
February 23, 2023 | finance.yahoo.com
BriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancer
January 23, 2023 | marketwatch.com
BriaCell to Investigate Potential Stock Manipulation
January 12, 2023 | stockhouse.com
BriaCell Announces New Patent Issuance, Bria-OTS(TM) IND Timing Guidance, and Additional Clinical Sites to Boost Enrolment
January 10, 2023 | msn.com
BriaCell to get US, Australian patent linked to personalized cancer immunotherapy
August 5, 2022 | bizjournals.com
BriaCell signs exclusive licensing deal with UMBC for cancer treatment candidate
July 21, 2022 | finance.yahoo.com
BriaCell Therapeutics Corp. (TSE:BCT) insider upped their holding earlier this year
See More Headlines
Receive BCTXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:BCTXF
CUSIP
N/A
CIK
N/A
Web
www.briacell.com
Phone
(604) 921-1810
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($3.84)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,680,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-786.77%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.07

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($4.55) per share
Price / Book
-0.44

Miscellaneous

Outstanding Shares
772,000
Free Float
N/A
Market Cap
$1.56 million
Optionable
Not Optionable
Beta
1.09
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • William V. Williams
    President, Chief Executive Officer & Director
  • Gadi Levin
    Chief Financial Officer & Secretary
  • Farrah Dean
    Manager-Corporate Development & IR Contact

Key Competitors

View All Competitors

BCTXF Stock Analysis - Frequently Asked Questions

How have BCTXF shares performed in 2024?

BriaCell Therapeutics' stock was trading at $5.85 at the start of the year. Since then, BCTXF stock has decreased by 65.5% and is now trading at $2.02.
View the best growth stocks for 2024 here.

How do I buy shares of BriaCell Therapeutics?

Shares of BCTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BCTXF) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends